维普期刊资源整合服务平台（V6.5）

177篇 您的检索式：作者名="Ehrmann DA"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	Effects of race and family history of type 2 diabetes on metabolie status of women withpolycystie ovary syndrome显示文摘	Ehrmann DA Kasza K Azziz R	2005	J Clin Endocrinol Metab2005，90，1：	1
2	Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome显示文摘	Ehrmann DA Barnes RB Rosenfield RL	1999	Diabetes Care1999，22，：	1
3	Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome显示文摘	Ehrmann DA Liljenquist DR Kasza K		0，，：	1
4	Diagnosis and treatment of polyeystic ovary syndrome: an Endocrine Society clinical prac- tice guideline 显示文摘	Legro RS Arslanian SA Ehrmann DA	2013	J Clin Endocrinol Metab2013，98，12：	1
5	Diagnosis and treatment of polycystic ovary syndrome:Society clinical practice guidline显示文摘	Legro RS Arslanian SA Ehrmann DA	2012	J Clin Endocrinol Metab2012，98，12：	1
6	Polycystic ovary syndrome显示文摘	Ehrmann DA	2005	N Engl J Mcd2005，352，：	1
7	Polycystic ovary syndrome asa form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion显示文摘	Ehrmann DA Barnes RB Rosenfield RL	1995	Endocr Rev1995，16，32：	1
8	Androgens and mood dysfunction in women : comparison of women with polyeystie ovarian syndrome to healthy controls显示文摘	Weiner CL Primeau M Ehrmann DA	2004	Psychosom Med2004，66，：	1
9	Diagnosis and treatment of polycystie ovary syndrome: an Endocrine Society clinical practice guideline显示文摘	Legro RS Arslanian SA Ehrmann DA	2013	J Clin Endocrinol Metab2013，98，12：	1
10	Polycystic ovary syndrome显示文摘	Ehrmann DA	2005	N Engl J Med2005，352，12：	1
11	Slow-wave sleep and the risk of type 2 diabetes in humans显示文摘	Tasali E Leprouh R Ehrmann DA	2008	Proc Natl Acad Sci USA2008，105，：	1
12	Slow wave sleep and the risk of type 2 diabetes in humans显示文摘	Tasali E Leproult R Ehrmann DA		0，，：	1
13	Polycystic ovary syndrome 显示文摘	Ehrmann DA	2005	N Engl J Med2005，352，12：	1
14	Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion显示文摘	Ehrmann DA Barnes RB Rosenfield RL	1995	Endocr Rev1995，16，3：	1
15	Polycystic ovary syndrome 显示文摘	Ehrmann DA	2005	N Engl J Med2005，352，7：	1
16	Troglitazone improve defect in insulin action,insulin secretion,ovarian steroielgengsis and fibrinolysis in women with polycystic ovary syndrome显示文摘	Ehrmann DA Schnoider DJ Sobel BE	1997	J Clin Endocrinol Metab1997，82，7：	1
17	Troglitazone improves defects in insulin action,insulin secretion,ovarian steroidogenesis,and fibrinolysis in women with polycystic ovary syndrome显示文摘	Ehrmann DA Schneider DJ Sobel BE	1997	J Clin Endocrinol Metab1997，82，7：	1
18	Troglitazone improve defects in isulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome 显示文摘	Ehrmann DA Schneider DJ Sobel BE	1997	J Clin Endocriol Motabolism1997，82，7：	1
19	Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome显示文摘	Ehrmann DA Liljenquist DR Kasza K	2006	J Clin Endocrinol Metab2006，91，：	1
20	Polycystic ovary syndrome显示文摘	Ehrmann DA		0，，：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示